Jacob Odeberg
Fundador en Cytacoat AB .
Perfil
Jacob Odeberg is the founder of Cytacoat AB.
He is currently the Director at Helicure AB and an Associate Professor at the Royal Institute of Technology.
Previously, he worked as the Deputy Director at The Kempe Foundation for the Prevention & Treatment.
Cargos activos de Jacob Odeberg
| Empresas | Cargo | Inicio |
|---|---|---|
Helicure AB
 Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Director/Miembro de la Junta | - |
| Royal Institute of Technology | Corporate Officer/Principal | - |
| Cytacoat AB | Fundador | 17/05/2011 |
Antiguos cargos conocidos de Jacob Odeberg.
| Empresas | Cargo | Fin |
|---|---|---|
The Kempe Foundation for the Prevention & Treatment
 The Kempe Foundation for the Prevention & Treatment Miscellaneous Commercial ServicesCommercial Services The Kempe Foundation for the Prevention and Treatment of Child Abuse and Neglect provides treatment and prevention programs for abused children. It offers clinical care, advocacy, research, education, and national and international work. The company was founded in 1976 and is headquartered in Aurora, CO. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Helicure AB
Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Health Technology |
| Cytacoat AB | |
The Kempe Foundation for the Prevention & Treatment
The Kempe Foundation for the Prevention & Treatment Miscellaneous Commercial ServicesCommercial Services The Kempe Foundation for the Prevention and Treatment of Child Abuse and Neglect provides treatment and prevention programs for abused children. It offers clinical care, advocacy, research, education, and national and international work. The company was founded in 1976 and is headquartered in Aurora, CO. | Commercial Services |
- Bolsa de valores
- Insiders
- Jacob Odeberg
